Estrella Immunopharma, Inc. business relationships
Companies named in Estrella Immunopharma, Inc.’s 10-K filed 2026-03-18, and public companies whose annual reports name Estrella Immunopharma, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.2 / 10
- AI naming
- <1 / 100 Top 6% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in Estrella Immunopharma, Inc.’s annual report 1
“| License Agreement, dated June 28, 2022, by and among Eureka Therapeutics, Inc., Eureka Therapeutics (Cayman) Ltd. and Estrella Immunopharma, Inc. incorporated by reference to Exhibit 10.4 to the registration statement on Form S-4/A filed with the SEC on July 7, 2023 (File No. 333-267918) |” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.